Drug Trial Radar · NCT04542057
A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Last checked: Nov 20, 2026Latest source record: Oct 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
790
Actual
Start
Sep 22, 2020
Primary completion
May 3, 2022
Study completion Jul 6, 2022
Sponsor
- Lead sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USAIndustry
- Sponsor type
- Industry
- Collaborators
- IQVIA Pty Ltd
- First posted
- Sep 9, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if ensifentrine is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
EnsifentrineDrug
Dosage Formulation: Ensifentrine Nebulizer suspension Dosage 3mg Frequency: Twice Daily for 24 weeks
PlaceboDrug
Dosage Formulation: Ensifentrine Placebo Nebulizer solution Frequency: Twice Daily for 24 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Least Square (LS) Mean Change From Baseline in Average Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve Over 12 Hours (AUC0-12h) at Week 12Time frame: Baseline (40 minutes before first administration on Day 1) and Week 12
Locations
130 sites in 10 countries. Site status is shown where the registry gives one.
Wright Clinical Research, LLC
Alabaster, Alabama
SEC Clinical Research
Andalusia, Alabama
Jasper Summit Research LLC
Jasper, Alabama
Pulmonary Associates Clinical Trials
Phoenix, Arizona
Elite Clinical Studies LLC
Phoenix, Arizona
Clinical Research Institute of Arizona, LLC
Sun City West, Arizona
Premier Medical Group
Bakersfield, California
Antelope Valley Clinical Trials
Lancaster, California
Downtown LA Research Center, Inc.
Los Angeles, California
UCLA Medical Center
Los Angeles, California
California Medical Research Associates
Northridge, California
Center for Clinical Trials of Sacramento, Inc.
Sacramento, California
Integrated Research Center
San Diego, California
Institute of HealthCare Assessment, Inc.
San Diego, California
Alpine Clinical Research Center
Boulder, Colorado
Innovative Research of West Florida
Clearwater, Florida
Clinical Research of West Florida, Inc.
Clearwater, Florida
Accel Research Sites - DeLand Clinical Research Unit
DeLand, Florida
Riverside Clinical Research
Edgewater, Florida
Medical Research of Central Florida
Leesburg, Florida
Axcess Medical Research
Loxahatchee Groves, Florida
Research Institute of South Florida
Miami, Florida
Advanced Medical Research Institute
Miami, Florida
Clinical Trials of Florida. LLC
Miami, Florida
South Medical Research Group, Inc.
Miami, Florida
ProCare Clinical Research
Miami Gardens, Florida
HMD Research, LLC
Orlando, Florida
Florida Institute for Clinical Research
Orlando, Florida
Sarasota Clinical Research
Sarasota, Florida
Coastal Pulmonary Critical Care
St. Petersburg, Florida
Pasadena Center for Medical Research, LLC
St. Petersburg, Florida
Clinical Research of West Florida, Inc.
Tampa, Florida
Clinical Research Trials of Florida, Inc.
Tampa, Florida
Florida Pulmonary Research Institute, LLC
Winter Park, Florida
AMR New Orleans
New Orleans, Louisiana
Genesis Clin RES& Consulting
Fall River, Massachusetts
Minnesota Lung Center
Edina, Minnesota
Minnesota Lung Center
Woodbury, Minnesota
Midwest Chest Consultants
Saint Charles, Missouri
Montana Medical Research Inc.
Missoula, Montana
Showing 40 of 130 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.